Gene · 6528
Papers4,585
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,585
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multifunctional nanoparticle-mediated combining therapy for human diseases. | Signal Transduct Target Ther | 2024 | 38161204 | PubTator, text mining | PubMed |
| Anoikis-related gene CDKN2A predicts prognosis and immune response and mediates proliferation and migration in thyroid carcinoma. | Transl Oncol | 2024 | 38141377 | PubTator, text mining | PubMed |
| IL-10-TG/TPO-T4 axis, the target of bis (2-ethylhexyl) tetrabromophthalate on thyroid function imbalance. | Toxicology | 2024 | 38135142 | PubTator, text mining | PubMed |
| Real-World Characteristics of Patients with Severe Asthma prior to Starting Dupilumab: The ProVENT Study. | Respiration | 2024 | 38086344 | PubTator, text mining | PubMed |
| Graves' disease with only unilateral involvement; a case report. | Int J Surg Case Rep | 2024 | 38086135 | PubTator, text mining | PubMed |
| Genetic Engineering of Therapeutic Cells with the Sodium Iodide Symporter (NIS) to Enable Noninvasive In Vivo Therapy Tracking. | Methods Mol Biol | 2024 | 38006504 | PubTator, text mining | PubMed |
| Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids. | Oncogene | 2024 | 37985676 | PubTator, text mining | PubMed |
| Combined Vorinostat and Chloroquine Inhibit Sodium-Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo. | Clin Cancer Res | 2024 | 37921808 | PubTator, text mining | PubMed |
| HIF-1α regulates the cell viability in radioiodine-resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF-κB signaling pathway. | Mol Carcinog | 2024 | 37861358 | PubTator, text mining | PubMed |
| The relationship between thyroid and human-associated microbiota: A systematic review of reviews. | Rev Endocr Metab Disord | 2024 | 37824030 | PubTator, text mining | PubMed |
| Temporary Thyroid Dysfunction and Catecholamine Excess Due to Mercury Poisoning in 6 Cases. | Turk Arch Pediatr | 2024 | 37818842 | PubTator, text mining | PubMed |
| Interface engineering of NiS/NiCo2S4 heterostructure with charge redistribution for boosting overall water splitting. | J Colloid Interface Sci | 2024 | 37751675 | PubTator, text mining | PubMed |
| Role of Mediterranean diet in endocrine diseases: a joint overview by the endocrinologist and the nutritionist. | J Endocrinol Invest | 2024 | 37697017 | PubTator, text mining | PubMed |
| Fusion Oncogenes in Patients With Locally Advanced or Distant Metastatic Differentiated Thyroid Cancer. | J Clin Endocrinol Metab | 2024 | 37622214 | PubTator, text mining | PubMed |
| Implementing the immunization agenda 2030: A framework for action through coordinated planning, monitoring & evaluation, ownership & accountability, and communications & advocacy. | Vaccine | 2024 | 36639274 | PubTator, text mining | PubMed |
| Pathogenesis and signaling pathways related to iodine-refractory differentiated thyroid cancer. | Front Endocrinol (Lausanne) | 2023 | 38313845 | PubTator, text mining | PubMed |
| Therapeutic potential of oncolytic viruses in the era of precision oncology. | Biomater Transl | 2023 | 38283919 | PubTator, text mining | PubMed |
| Oncolytic vaccinia virus and cancer immunotherapy. | Front Immunol | 2023 | 38283361 | PubTator, text mining | PubMed |
| Brain-derived neurotrophic factor (BDNF): an effect biomarker of neurodevelopment in human biomonitoring programs. | Front Toxicol | 2023 | 38268968 | PubTator, text mining | PubMed |
| Research progress of plant-derived natural products in thyroid carcinoma. | Front Chem | 2023 | 38268761 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6528/papers?page=17